Why Sagimet Biosciences Inc.’s (SGMT) Stock Is Down 5.82%
As of Friday, November 20, Sagimet Biosciences Inc.’s SGMT share price has dipped by 5.82%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
Jenna Brashear
| Share Statistics | SGMT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $648.0 | $203.5 | 42% |
|
| Shares Out (Mil) | 62.3 | 55.2 | 52% |
|
| Institutional Ownership | 98.9% | 93.3% | 83% |
|
| Float (Mil) | 59.9 | 40.4 | 50% |
|
| Beta | 3.47 | 1.05 | 98% |
|
| Avg Daily Volume (000s) | 1,199 | 569 | 72% |
|
| Price Change (52-week) |
15.7% | 38.8% | 69% |
|
| Growth | SGMT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (34.9%) | (10.7%) | 11% |
|
| EPS (5yr) | 57.8% | 15.4% | 95 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (14.9%) | (15.7%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 11 | 11 | |
| Current EPS | ($0.304) | ($1.206) | ($1.418) | |
| Month Ago EPS | ($0.276) | ($1.121) | ($1.301) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.295) | ($1.198) | ($1.341) | |
| Year/Year Chg | (1.0%) | (23.6%) | 0.6% | |
| Financials | SGMT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $40 | na |
|
| Net Income (TTM) (Mil) | ($53) | ($44) | 15% |
|
| EPS (TTM) | ($1.179) | ($1.400) | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($44) | ($35) | 10% |
|
| Net Cash Flow (TTM) (Mil) | na | $-0 | na |
|
| Long-Term Debt (Q1) (Mil) | $2 | $4 | 19% |
|
| Enterprise Value (Q1) (Mil) | $449 | $142 | 34% |
|
| Valuation | SGMT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.35 | 1.96 | 64% |
|
| P/E | na | 16.9 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | SGMT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.6% | na |
|
| Net Margin | na | (50.8%) | na |
|
| ROA | (26.0%) | (47.0%) | 17% |
|
| ROE | (29.5%) | (51.8%) | 20% |
|
| Liabilities to Assets | 14.1% | 29.6% | 9% |
|
| F-Score | 2 | 3 | 7% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.1% |
| +/- S&P 500: | -5.3 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors